Back to search
FDAFDA · Food and drugs·Recall number D-0136-2020

10% LMD in 5% Dextrose Injection Dextran 40 in Dextrose Injection, USP, 500 mL bags, Rx only, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-7418-13

Published October 16, 2019 · Recall initiated: October 2, 2019

Summary

FDA records drug Class II recall D-0136-2020, published October 16, 2019 and initiated October 2, 2019. Recalling firm: Pfizer Inc.; Status: Terminated; Reported quantity: 17832 bags; Lot: Lot #: 87-095-JT Exp. 1MAR2020. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Assurance of Sterility: Bag has the potential to leak.

What to do

Voluntary: Firm initiated · Letter

Get an email if LMD IN DEXTROSE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
LMD IN DEXTROSE
Manufacturer
Pfizer Inc.
Distributor
Nationwide in the United States and Puerto Rico
Lot
Lot #: 87-095-JT Exp. 1MAR2020
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was 10% LMD in 5% Dextrose Injection Dextran 40 in Dextrose Injection, USP, 500 mL bags, Rx only, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-7418-13 recalled?

Yes. FDA published recall D-0136-2020 on October 16, 2019. Reported hazard: Lack of Assurance of Sterility: Bag has the potential to leak.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: LMD IN DEXTROSE.